Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer
Conditions: Rectal Cancer Interventions: Drug: irinotecan liposomes+capecitabine Sponsors: Zhejiang Cancer Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hospitals | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Rectal Cancers | Research | Xeloda